Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
CAPRICOR THERAPEUTICS, INC. (CAPR)
Standardized SEC financial data for CAPRICOR THERAPEUTICS, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001133869 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-100.0%
Return on equity
-34.4%
Free cash flow
-$72.7M
Current ratio
9.01×
EPS (diluted)
$-2.26
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$310K
$245K
$2.6M
$25.2M
$22.3M
$0
R&D expense
$8.5M
$13.6M
$21.8M
$36.4M
$50.0M
$84.5M
SG&A expense
$5.5M
$7.6M
$10.4M
$12.8M
$14.9M
$23.7M
Operating income
-$13.7M
-$20.9M
Standardized from CAPRICOR THERAPEUTICS, INC.'s SEC filings — per-share figures split-adjusted. Full history via the API.